It is possible that SV40 may induce a growth advantage of MM cells, inactivating both cell cycle regulatory proteins and inducing increased or inhibition expression of specific growth factors and cytokines [39], [42]. This evidence concerns the gene RCC1 and Miyoshi myopathy.